PubRank

C Coulibaly

Author PubWeight™ 28.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol 1993 3.37
2 Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies. J Virol 1999 1.72
3 vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol 1995 1.51
4 Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J Acquir Immune Defic Syndr Hum Retrovirol 1998 1.23
5 Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology 1992 1.09
6 Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus. AIDS 1993 1.02
7 The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 1996 0.97
8 [Comparison of the therapeutic efficacy of the so-called heavy and lightened antitubercular regimens]. Bull Int Union Tuberc 1986 0.95
9 Alterations of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection. Am J Pathol 1993 0.92
10 Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol 2002 0.91
11 Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet Immunol Immunopathol 1993 0.90
12 Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo. Virology 1996 0.89
13 Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo. Arch Virol 2002 0.89
14 Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. J Gen Virol 1995 0.88
15 Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques. Am J Vet Res 1994 0.87
16 In vitro and in vivo infection of rhesus monkey microglial cells by simian immunodeficiency virus. Virology 1993 0.86
17 Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J Virol 1995 0.86
18 Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC. AIDS Res Hum Retroviruses 1992 0.83
19 Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. J Med Primatol 1994 0.83
20 The thymic epithelial reticulum and interdigitating cells in SIV-induced thymus atrophy and its comparison with other forms of thymus involution. Res Virol 1993 0.83
21 Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques. J Gen Virol 1992 0.83
22 Protection of cynomolgus macaques (Macaca fascicularis) against infection with the human immunodeficiency virus type 2 strain ben (HIV-2ben) by immunization with the virion-derived envelope glycoprotein gp130. AIDS Res Hum Retroviruses 1993 0.81
23 Comparative analysis of monoclonal antibodies against pestiviruses: report of an international workshop. Vet Microbiol 1989 0.81
24 Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. AIDS Res Hum Retroviruses 1994 0.80
25 Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys. J Med Primatol 1993 0.77
26 Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: correlation with viremia, disease progression, and seroconversion to structural viral proteins. Virology 1991 0.77
27 Autoantibody-mediated platelet phagocytosis in SIV-infected macaques. AIDS 1994 0.76
28 Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130. J Gen Virol 1993 0.76
29 Simian immunodeficiency virus (SIV) induced alterations of thymus IDCs. Adv Exp Med Biol 1993 0.75
30 [Cylindroma of the salivary glands. Various aspects apropos of 10 cases from the Ivory Coast]. Rev Stomatol Chir Maxillofac 1990 0.75
31 SIV- and HIV-2-neutralising antibodies in infected macaques measured by a novel and simple neutralisation test based on a non-commercial antigen-ELISA. J Virol Methods 1994 0.75
32 A spontaneous uterine sarcoma in a rhesus monkey (Macaca mulatta). J Vet Med A Physiol Pathol Clin Med 2002 0.75
33 [Xerostomia. Current data and perspectives]. Rev Stomatol Chir Maxillofac 1994 0.75